<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35260465</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study.</ArticleTitle><Pagination><StartPage>e060102</StartPage><MedlinePgn>e060102</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e060102</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2021-060102</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Early detection and tracking of bulbar dysfunction in amyotrophic lateral sclerosis (ALS) are critical for directing management of the disease. Current clinical bulbar assessment tools are lacking, while existing physiological instrumental assessments are often inaccessible and cost-prohibitive for clinical application. The goal of our research is to develop and validate a brief and reliable, clinician-administered assessment tool-the ALS-Bulbar Dysfunction Index (ALS-BDI). This publication describes the study protocol that has been established to ascertain the tools' psychometric properties.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">The ALD-BDI's development closely follows guidelines outlined by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). Through the proposed study protocol, we expect to establish psychometric properties of both individual test items of the ALS-BDI as well as the final version of the entire tool, including test-retest and inter-rater reliability, construct validity using gold-standard assessment methods and responsiveness.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">This study has been reviewed and approved by research ethics boards at two data collection sites: Sunnybrook Health Science Centre, primary (Toronto, Canada; ID3080) and Mass General Brigham (#2013P001746, Boston, USA). Prior to participation in the study, the participants sign the informed consent in accordance with the Declaration of Helsinki. Once validated, the ALS-BDI will be disseminated to key stakeholders. Following validation, the ALS-BDI and any required training material will be implemented for clinical use in a context of a multidisciplinary ALS clinic and used as an outcome measure for clinical trials in ALS research.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yunusova</LastName><ForeName>Yana</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2353-2275</Identifier><AffiliationInfo><Affiliation>Department of Speech-Language Pathology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada yana.yunusova@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waito</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnett</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rehabilitation Sciences Institute, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Speech-Language Pathology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahao</LastName><ForeName>Agessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattee</LastName><ForeName>Gary L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Neurology Associates P.C, Lincoln, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Jordan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Speech and Hearing Biosciences and Technology, Harvard University, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DC017291</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">motor neurone disease</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">rehabilitation medicine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35260465</ArticleId><ArticleId IdType="pmc">PMC8905936</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2021-060102</ArticleId><ArticleId IdType="pii">bmjopen-2021-060102</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Armon C, Graves MC, Moses D, et al. . Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000;23:874&#x2013;82. 10.1002/(sici)1097-4598(200006)23:6&amp;lt;874::aid-mus5&amp;gt;3.0.co;2-u</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4598(200006)23:6&amp;lt;874::aid-mus5&amp;gt;3.0.co;2-u</ArticleId><ArticleId IdType="pubmed">10842262</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Suckling J, et al. . Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005;252:321&#x2013;31. 10.1007/s00415-005-0646-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0646-x</ArticleId><ArticleId IdType="pubmed">15739047</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology 2005;64:1222&#x2013;6. 10.1212/01.WNL.0000156519.41681.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000156519.41681.27</ArticleId><ArticleId IdType="pubmed">15824350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 2013;12:368&#x2013;80. 10.1016/S1474-4422(13)70026-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70026-7</ArticleId><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. validation of a scoring system and a model for survival prediction. Brain 1995;118 (Pt 3:707&#x2013;19. 10.1093/brain/118.3.707</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/118.3.707</ArticleId><ArticleId IdType="pubmed">7600088</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Scaber J, Goodfellow JA, et al. . The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci 2010;294:81&#x2013;5. 10.1016/j.jns.2010.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.03.028</ArticleId><ArticleId IdType="pubmed">20452624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310&#x2013;23. 10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecht M, Hillemacher T, Gr&#xe4;sel E, et al. . Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3:225&#x2013;31. 10.1080/146608202760839009</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760839009</ArticleId><ArticleId IdType="pubmed">12710513</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman EK, Tabor LC, Wymer J, et al. . The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:351&#x2013;7. 10.1080/21678421.2017.1313868</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313868</ArticleId><ArticleId IdType="pmc">PMC7001984</ArticleId><ArticleId IdType="pubmed">28425762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985;38:27&#x2013;36. 10.1016/0021-9681(85)90005-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(85)90005-0</ArticleId><ArticleId IdType="pubmed">3972947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink LB, Prinsen CAC, Bouter LM, et al. . The consensus-based standards for the selection of health measurement instruments (COSMIN) and how to select an outcome measurement instrument. Braz J Phys Ther 2016;20:105&#x2013;13. 10.1590/bjpt-rbf.2014.0143</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/bjpt-rbf.2014.0143</ArticleId><ArticleId IdType="pmc">PMC4900032</ArticleId><ArticleId IdType="pubmed">26786084</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamantopoulos A, Siguaw JA. Formative versus reflective indicators in organizational measure development: a comparison and empirical illustration. Br J Nurs 2006;17:263&#x2013;82.</Citation></Reference><Reference><Citation>Yunusova Y, Waito A, Barnett-Tapia C. A novel ALS bulbar dysfunction index (ALS-BDI): establishing face and content validity. 20th Biennial Conference on Motor Speech: conference proceedings, Santa Barbara, California, USA: Madonna Rehabilitation Hospitals, 2020:19&#x2013;23.</Citation></Reference><Reference><Citation>Pattee GL, Plowman EK, Brooks BR, et al. . Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar Subcommittee symposium. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:311&#x2013;2. 10.1080/21678421.2017.1404109</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1404109</ArticleId><ArticleId IdType="pubmed">29205054</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Plowman EK, Green JR, et al. . Clinical measures of bulbar dysfunction in ALS. Front Neurol 2019;10:106. 10.3389/fneur.2019.00106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00106</ArticleId><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al. . The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695&#x2013;9. 10.1111/j.1532-5415.2005.53221.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13&#x2013;21. 10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005;85:257&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">15733050</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo TK, MY L. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15(2):155-63. 10.1016/j.jcm.2016.02.012 [published Online first: 2016/06/23] Erratum in. J Chiropr Med 2017;16:346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420&#x2013;8. 10.1037//0033-2909.86.2.420</Citation><ArticleIdList><ArticleId IdType="doi">10.1037//0033-2909.86.2.420</ArticleId><ArticleId IdType="pubmed">18839484</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnally JC. Psychometric theory. New York, NY: McGraw-Hill, 1967.</Citation></Reference><Reference><Citation>Kraemer HC, Korner AF. Statistical alternatives in assessing reliability, consistency, and individual differences for quantitative measures: application to behavioral measures of neonates. Psychol Bull 1976;83:914&#x2013;21. 10.1037/0033-2909.83.5.914</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.83.5.914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RA, Macklin EA, Myers KJ. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale). Eur J Neurol 2018;25(7):907-e66. 10.1111/ene.13638 [published Online First: 2018/03/27] Erratum in. Eur J Neurol 2018;25:1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6005752</ArticleId><ArticleId IdType="pubmed">29577526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludlow CL, Kent RD, Gray LC, et al. . Speech, and swallowing in the clinic and laboratory. San Diego, CA: Plural Publishing, Inc, 2018.</Citation></Reference><Reference><Citation>Tabor-Gray LC, Gallestagui A, Vasilopoulos T, et al. . Characteristics of impaired voluntary cough function in individuals with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:37&#x2013;42. 10.1080/21678421.2018.1510011</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1510011</ArticleId><ArticleId IdType="pmc">PMC6513719</ArticleId><ArticleId IdType="pubmed">30652513</ArticleId></ArticleIdList></Reference><Reference><Citation>Youmans SR, Stierwalt JAG. Measures of tongue function related to normal swallowing. Dysphagia 2006;21:102&#x2013;11. 10.1007/s00455-006-9013-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-006-9013-z</ArticleId><ArticleId IdType="pubmed">16685469</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams V, Mathisen B, Baines S, et al. . A systematic review and meta-analysis of measurements of tongue and hand strength and endurance using the Iowa oral performance instrument (IOPI). Dysphagia 2013;28:350&#x2013;69. 10.1007/s00455-013-9451-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-013-9451-3</ArticleId><ArticleId IdType="pubmed">23468283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandini A, Green JR, Taati B. Automatic detection of amyotrophic lateral sclerosis (ALS) from video-based analysis of facial movements: speech and non-speech tasks. 13th IEEE International Conference on Automatic Face and Gesture Recognition, FG 2018: conference proceedings, 2018:150&#x2013;7.</Citation></Reference><Reference><Citation>Berry JJ. Accuracy of the NDI wave speech research system. J Speech Lang Hear Res 2011;54:1295&#x2013;301. 10.1044/1092-43882011/10-0226</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1092-43882011/10-0226</ArticleId><ArticleId IdType="pubmed">21498575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S, Green JR, Kulkarni M, et al. . Speech movement measures as markers of bulbar disease in amyotrophic lateral sclerosis. J Speech Lang Hear Res 2016;59:887&#x2013;99. 10.1044/2016_JSLHR-S-15-0238</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2016_JSLHR-S-15-0238</ArticleId><ArticleId IdType="pmc">PMC5345561</ArticleId><ArticleId IdType="pubmed">27679842</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett C, Green JR, Marzouqah R, et al. . Reliability and validity of speech &amp; pause measures during passage reading in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2020;21:42&#x2013;50. 10.1080/21678421.2019.1697888</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1697888</ArticleId><ArticleId IdType="pmc">PMC7080316</ArticleId><ArticleId IdType="pubmed">32138555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkston KM, Beukelman DR, Hakel M. Speech intelligibility test for windows. communication disorders software, 1996.</Citation></Reference><Reference><Citation>Rosenbek JC, Robbins JA, Roecker EB, et al. . A penetration-aspiration scale. Dysphagia 1996;11:93&#x2013;8. 10.1007/BF00417897</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00417897</ArticleId><ArticleId IdType="pubmed">8721066</ArticleId></ArticleIdList></Reference><Reference><Citation>Waito AA, Plowman EK, Barbon CEA, et al. . A cross-sectional, quantitative videofluoroscopic analysis of swallowing physiology and function in individuals with amyotrophic lateral sclerosis. J Speech Lang Hear Res 2020;63:948&#x2013;62. 10.1044/2020_JSLHR-19-00051</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2020_JSLHR-19-00051</ArticleId><ArticleId IdType="pmc">PMC7242989</ArticleId><ArticleId IdType="pubmed">32310713</ArticleId></ArticleIdList></Reference><Reference><Citation>Waito AA, Tabor-Gray LC, Steele CM, et al. . Reduced pharyngeal constriction is associated with impaired swallowing efficiency in amyotrophic lateral sclerosis (ALS). Neurogastroenterol Motil 2018;30:e13450. 10.1111/nmo.13450</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13450</ArticleId><ArticleId IdType="pmc">PMC6249041</ArticleId><ArticleId IdType="pubmed">30129164</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard R, Rees CJ, Belafsky P, et al. . Fluoroscopic surrogate for pharyngeal strength: the pharyngeal constriction ratio (PCR). Dysphagia 2011;26:13&#x2013;17. 10.1007/s00455-009-9258-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-009-9258-4</ArticleId><ArticleId IdType="pmc">PMC3052447</ArticleId><ArticleId IdType="pubmed">19856026</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman EK, Watts SA, Robison R, et al. . Voluntary cough airflow differentiates safe versus unsafe swallowing in amyotrophic lateral sclerosis. Dysphagia 2016;31:383&#x2013;90. 10.1007/s00455-015-9687-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-015-9687-1</ArticleId><ArticleId IdType="pmc">PMC4871758</ArticleId><ArticleId IdType="pubmed">26803772</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Gray L, Vasilopoulos T, Plowman EK. Differences in voluntary and reflexive cough strength in individuals with amyotrophic lateral sclerosis and healthy adults. Muscle Nerve 2020;62:597&#x2013;600. 10.1002/mus.27040</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27040</ArticleId><ArticleId IdType="pubmed">32776561</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vet HCW, Terwee CB, Mokkink LB. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press, 2011.</Citation></Reference><Reference><Citation>Terwee CB, Dekker FW, Wiersinga WM, et al. . On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12:349&#x2013;62. 10.1023/a:1023499322593</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1023499322593</ArticleId><ArticleId IdType="pubmed">12797708</ArticleId></ArticleIdList></Reference><Reference><Citation>Juniper EF, Guyatt GH, Willan A, et al. . Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81&#x2013;7. 10.1016/0895-4356(94)90036-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(94)90036-1</ArticleId><ArticleId IdType="pubmed">8283197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedeker DR, Gibbons RD. Longitudinal data analysis. Hoboken, N.J: Wiley-Interscience, 2006.</Citation></Reference><Reference><Citation>Ruoppolo G, Schettino I, Frasca V, et al. . Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. Acta Neurol Scand 2013;128:397&#x2013;401. 10.1111/ane.12136</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12136</ArticleId><ArticleId IdType="pubmed">23668293</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang MH, Larson MG, Cullen KE, et al. . Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542&#x2013;7. 10.1002/art.1780280513</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780280513</ArticleId><ArticleId IdType="pubmed">4004963</ArticleId></ArticleIdList></Reference><Reference><Citation>King MT. A point of minimal important difference (mid): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 2011;11:171&#x2013;84. 10.1586/erp.11.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erp.11.9</ArticleId><ArticleId IdType="pubmed">21476819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Boers M, Shea B, et al. . MCID/Low disease activity state workshop: low disease activity state in rheumatoid arthritis. J Rheumatol 2003;30:1110&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">12734918</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklyn K, Lau CS, Navarra SV, et al. . Definition and initial validation of a lupus low disease activity state (LLDAS). Ann Rheum Dis 2016;75:1615&#x2013;21. 10.1136/annrheumdis-2015-207726</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-207726</ArticleId><ArticleId IdType="pubmed">26458737</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubach F, Ravaud P, Baron G, et al. . Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005;64:34&#x2013;7. 10.1136/ard.2004.023028</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.023028</ArticleId><ArticleId IdType="pmc">PMC1755171</ArticleId><ArticleId IdType="pubmed">15130902</ArticleId></ArticleIdList></Reference><Reference><Citation>Puyraimond-Zemmour D, Etcheto A, Fautrel B, et al. . Associations between five important domains of health and the patient acceptable symptom state in rheumatoid arthritis and psoriatic arthritis: a cross-sectional study of 977 patients. Arthritis Care Res 2017;69:1504&#x2013;9. 10.1002/acr.23176</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23176</ArticleId><ArticleId IdType="pubmed">27998030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent RD. Hearing and believing: some limits to the auditory-perceptual assessment of speech and voice disorders. Am J Speech Lang Pathol 1996;5:7&#x2013;23.</Citation></Reference><Reference><Citation>Stipancic KL, Yunusova Y, Berry JD, et al. . Minimally detectable change and minimal clinically important difference of a decline in sentence intelligibility and speaking rate for individuals with amyotrophic lateral sclerosis. J Speech Lang Hear Res 2018;61:2757&#x2013;71. 10.1044/2018_JSLHR-S-17-0366</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2018_JSLHR-S-17-0366</ArticleId><ArticleId IdType="pmc">PMC6693567</ArticleId><ArticleId IdType="pubmed">30383220</ArticleId></ArticleIdList></Reference><Reference><Citation>KO SL, Ruscello DM. Oral speech mechanism screening examination (OSMSE). Baltimore, MD: University Park Press, 1981.</Citation></Reference><Reference><Citation>Rong P, Yunusova Y, Wang J, et al. . Predicting early bulbar decline in amyotrophic lateral sclerosis: a speech subsystem approach. Behav Neurol 2015;2015:183027&#x2013;11. 10.1155/2015/183027</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/183027</ArticleId><ArticleId IdType="pmc">PMC4468279</ArticleId><ArticleId IdType="pubmed">26136624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong P, Yunusova Y, Richburg B, et al. . Automatic extraction of abnormal lip movement features from the alternating motion rate task in amyotrophic lateral sclerosis. Int J Speech Lang Pathol 2018;20:610&#x2013;23. 10.1080/17549507.2018.1485739</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17549507.2018.1485739</ArticleId><ArticleId IdType="pmc">PMC6449219</ArticleId><ArticleId IdType="pubmed">30253671</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Green JR, Lindstrom MJ, et al. . Kinematics of disease progression in bulbar ALS. J Commun Disord 2010;43:6&#x2013;20. 10.1016/j.jcomdis.2009.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcomdis.2009.07.003</ArticleId><ArticleId IdType="pmc">PMC2813314</ArticleId><ArticleId IdType="pubmed">19683250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandini A, Green JR, Wang J, et al. . Kinematic features of jaw and lips distinguish symptomatic from presymptomatic stages of bulbar decline in amyotrophic lateral sclerosis. J Speech Lang Hear Res 2018;61:1118&#x2013;29. 10.1044/2018_JSLHR-S-17-0262</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2018_JSLHR-S-17-0262</ArticleId><ArticleId IdType="pmc">PMC6195078</ArticleId><ArticleId IdType="pubmed">29800359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandini A, Green JR, Zinman L. Classification of bulbar ALS from kinematic features of the jaw and lips: towards computer-mediated assessment. 18th Annual Conference of the International Speech Communication Association (INTERSPEECH, 2017): Situated Interaction: conference proceedings, 20172018.</Citation></Reference><Reference><Citation>Rong P, Yunusova Y, Green JR. Differential effects of velopharyngeal dysfunction on speech intelligibility during early and late stages of amyotrophic lateral sclerosis. 17th Annual Conference of the International Speech Communication Association (INTERSPEECH, 2016): Understanding Speech Processing in Humans and Machines: conference proceedings, 20162016.</Citation></Reference><Reference><Citation>Gauster A, Yunusova Y, Zajac D. The effect of speaking rate on velopharyngeal function in healthy speakers. Clin Linguist Phon 2010;24:576&#x2013;88. 10.3109/02699200903581042</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02699200903581042</ArticleId><ArticleId IdType="pubmed">20462360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressmann T, Sader R, Whitehill TL, et al. . Nasalance distance and ratio: two new measures. Cleft Palate Craniofac J 2000;37:248&#x2013;56. 10.1597/1545-1569_2000_037_0248_ndartn_2.3.co_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1597/1545-1569_2000_037_0248_ndartn_2.3.co_2</ArticleId><ArticleId IdType="pubmed">10830803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempster GB, Gerratt BR, Verdolini Abbott K, et al. . Consensus auditory-perceptual evaluation of voice: development of a standardized clinical protocol. Am J Speech Lang Pathol 2009;18:124&#x2013;32. 10.1044/1058-03602008/08-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1058-03602008/08-0017</ArticleId><ArticleId IdType="pubmed">18930908</ArticleId></ArticleIdList></Reference><Reference><Citation>Heman-Ackah YD, Heuer RJ, Michael DD, et al. . Cepstral peak prominence: a more reliable measure of dysphonia. Ann Otol Rhinol Laryngol 2003;112:324&#x2013;33. 10.1177/000348940311200406</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348940311200406</ArticleId><ArticleId IdType="pubmed">12731627</ArticleId></ArticleIdList></Reference><Reference><Citation>Awan SN, Solomon NP, Helou LB, et al. . Spectral-cepstral estimation of dysphonia severity: external validation. Ann Otol Rhinol Laryngol 2013;122:40&#x2013;8. 10.1177/000348941312200108</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348941312200108</ArticleId><ArticleId IdType="pubmed">23472315</ArticleId></ArticleIdList></Reference><Reference><Citation>Green JR, Beukelman DR, Ball LJ. Algorithmic estimation of pauses in extended speech samples of dysarthric and typical speech. J Med Speech Lang Pathol 2004;12:149&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902000</ArticleId><ArticleId IdType="pubmed">20628555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Green JR, Wang J. A protocol for comprehensive assessment of bulbar dysfunction in amyotrophic lateral sclerosis (ALS). J Vis Exp 2010;48. 10.3791/2422</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2422</ArticleId><ArticleId IdType="pmc">PMC3197394</ArticleId><ArticleId IdType="pubmed">21372794</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Graham NL, Shellikeri S, et al. . Profiling speech and pausing in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). PLoS One 2016;11:e0147573. 10.1371/journal.pone.0147573</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147573</ArticleId><ArticleId IdType="pmc">PMC4720472</ArticleId><ArticleId IdType="pubmed">26789001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanchip C, Yunusova Y, Waito AA. A complexity-based approach for automatic diadochokinesis analysis in amyotrophic lateral sclerosis (ALS). 20th Bienniel Biennial Conference on Motor Speech: conference proceedings, Santa Barbara, California, USA: Madonna Rehabilitation Hospitals, 2020.</Citation></Reference><Reference><Citation>Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. St. Louis: Mosby, 2005.</Citation></Reference><Reference><Citation>Nishio S, Niimi M. Changes over time in dysarthric patients with amyotrophic lateral sclerosis (ALS): a study of changes in speaking rate and maximum repetition rate (Mrr). Clin Linguist Phon 2000;14:485&#x2013;97. 10.1080/026992000750020323</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/026992000750020323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio M, Niimi S. Comparison of speaking rate, articulation rate and alternating motion rate in dysarthric speakers. Folia Phoniatr Logop 2006;58:114&#x2013;31. 10.1159/000089612</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089612</ArticleId><ArticleId IdType="pubmed">16479133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-T, Kent RD, Duffy JR, et al. . Analysis of diadochokinesis in ataxic dysarthria using the motor speech profile program. Folia Phoniatr Logop 2009;61:1&#x2013;11. 10.1159/000184539</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000184539</ArticleId><ArticleId IdType="pmc">PMC2790744</ArticleId><ArticleId IdType="pubmed">19088478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutcheson KA, Barrow MP, Barringer DA, et al. . Dynamic imaging grade of swallowing toxicity (digest): scale development and validation. Cancer 2017;123:62&#x2013;70. 10.1002/cncr.30283</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.30283</ArticleId><ArticleId IdType="pmc">PMC5161634</ArticleId><ArticleId IdType="pubmed">27564246</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele CM, Peladeau-Pigeon M, Nagy A, et al. . Measurement of pharyngeal residue from lateral view videofluoroscopic images. J Speech Lang Hear Res 2020;63:1404&#x2013;15. 10.1044/2020_JSLHR-19-00314</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2020_JSLHR-19-00314</ArticleId><ArticleId IdType="pmc">PMC7842118</ArticleId><ArticleId IdType="pubmed">32379520</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele CM, Peladeau-Pigeon M, Barbon CAE, et al. . Reference values for healthy swallowing across the range from thin to extremely thick liquids. J Speech Lang Hear Res 2019;62:1&#x2013;26. 10.1044/2019_JSLHR-S-18-0448</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2019_JSLHR-S-18-0448</ArticleId><ArticleId IdType="pmc">PMC6808317</ArticleId><ArticleId IdType="pubmed">31021676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>